Recent publications, ongoing prospective studies, and better knowledge of the available therapeutic options should provide the necessary framework for appropriate pain management in cancer-bearing pets.
Because you will likely encounter canine cutaneous mast cell tumors in your practice, this review article focuses on summarizing the therapeutic options available for treating canine mast cell tumors. With a better understanding of available treatment regimens, you will be able to educate and guide pet owners regarding the treatment options that may best suit their dogs.
Although amputation has traditionally been used to palliatively manage affected dogs, treatment modalities including limb salvage, radiation therapy, and chemotherapy are evolving. This overview of emerging therapies will help you educate owners about treatment options for dogs with appendicular osteosarcoma.
Cancer is a leading cause of death in pet dogs and cats. It is estimated that almost 50 percent of geriatric dogs and 33 percent of cats will die of cancer. As the pet population in the United States continues to age, cancer in pet animals is expected to become an even more significant problem in the field of animal health.
In this retrospective study from a veterinary teaching hospital, the medical records of 14 dogs with tumors of the retroperitoneal space (excluding those arising from the kidneys, adrenal glands, or ureters) were reviewed.
Localized primary tumors with a minimal risk for metastasis are commonly treated with surgery or radiation. But chemotherapy may occasionally be used to treat these tumors instead of or in addition to standard local therapy.
Technological advances and practitioner compliance appear to have lessened the risk of cancer in veterinarians, although potentially carcinogenic exposures are still an unfeigned threat to the profession.